AlzeCure Pharma Book Value Per Share vs. Current Ratio
| ALZCUR Stock | SEK 1.21 0.01 0.83% |
For AlzeCure Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AlzeCure Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AlzeCure Pharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AlzeCure Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AlzeCure Pharma over time as well as its relative position and ranking within its peers.
AlzeCure |
AlzeCure Pharma Current Ratio vs. Book Value Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining AlzeCure Pharma's current stock value. Our valuation model uses many indicators to compare AlzeCure Pharma value to that of its competitors to determine the firm's financial worth. AlzeCure Pharma is number one stock in book value per share category among its peers. It also is number one stock in current ratio category among its peers fabricating about 76.63 of Current Ratio per Book Value Per Share. Comparative valuation analysis is a catch-all model that can be used if you cannot value AlzeCure Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AlzeCure Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.AlzeCure Current Ratio vs. Book Value Per Share
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
AlzeCure Pharma |
| = | 0.63 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
AlzeCure Pharma |
| = | 48.05 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
AlzeCure Current Ratio Comparison
AlzeCure Pharma is currently under evaluation in current ratio category among its peers.
AlzeCure Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in AlzeCure Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AlzeCure Pharma will eventually generate negative long term returns. The profitability progress is the general direction of AlzeCure Pharma's change in net profit over the period of time. It can combine multiple indicators of AlzeCure Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
AlzeCure Pharma AB develops therapies for the treatment of Alzheimer s disease and related neurodegenerative disorders. The company was founded in 2012 and is based in Huddinge, Sweden. AlzeCure Pharma is traded on Stockholm Stock Exchange in Sweden.
AlzeCure Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on AlzeCure Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AlzeCure Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AlzeCure Pharma's important profitability drivers and their relationship over time.
Use AlzeCure Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AlzeCure Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AlzeCure Pharma will appreciate offsetting losses from the drop in the long position's value.AlzeCure Pharma Pair Trading
AlzeCure Pharma Pair Trading Analysis
The ability to find closely correlated positions to AlzeCure Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AlzeCure Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AlzeCure Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AlzeCure Pharma to buy it.
The correlation of AlzeCure Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AlzeCure Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AlzeCure Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AlzeCure Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your AlzeCure Pharma position
In addition to having AlzeCure Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cryptocurrency ETFs Thematic Idea Now
Cryptocurrency ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Cryptocurrency ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in AlzeCure Stock
To fully project AlzeCure Pharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of AlzeCure Pharma at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include AlzeCure Pharma's income statement, its balance sheet, and the statement of cash flows.